Latest Posts

Getting By, Getting Ahead: Start-Up Entrepreneur Brings High-Tech Talent To Rural N.H.

"We're in an industry that is not entirely recession-proof," says Adimab co-founder and CEO Tillman Gerngross.  "But the drug industry is a lot less volatile and subject to discretionary spending, because people get sick and they need drugs.  Fortunately, we've been able to establish a sort of leadership position in the discovery of antibody-based therapies, and [the pharmaceutical industry] is very interested in accessing that capability."

As part of our weekly “Getting By, Getting Ahead” series, StateImpact is traveling across New Hampshire, gathering personal stories from the people behind the economy.  In our third installment, we visit a biotech start-up in the Dartmouth-Lake Sunapee region. _____ Deep inside a nondescript business park in Lebanon, a blocky, industrial building is getting a [...]

About StateImpact

StateImpact seeks to inform and engage local communities with broadcast and online news focused on how state government decisions affect your lives.
Learn More »